• SENSEX 79,040.03
    1,738.63 (+2.25%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
Back

Corporate News

Novelix Pharmaceuticals to review quarterly and half-year financials at November board meeting
04-Nov-2026, 07:31

Novelix Pharmaceuticals Limited, formerly TRIMURT HI LIMITED, will hold a board meeting on Wednesday, November 11, 2026, to consider and approve unaudited standalone financial results for the quarter and half year ended September 30, 2026, along with a limited review report from the auditors. The company, with Scrip Code 586565 and Scrip Id NOVELIX, has closed the trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the board meeting’s conclusion.